Zuranolone Improves Anxiety Symptoms and Insomnia in Women with Postpartum Depression
In women with postpartum depression, zuranolone was associated with concurrent improvements in depression, anxiety symptoms, and insomnia beginning at day 3.
When a New Baby Comes Home, Do Moms and Dads Get Depressed Together?
Should we also be assessing women’s partners to determine if they have postpartum depression?
Essential Reads: Transcranial Magnetic Stimulation for Perinatal Depression
TMS in pregnancy and the postpartum period appears to be a promising treatment option with no reports of adverse obstetric outcomes or congenital malformations.
Paid Parental Leave: A Novel Approach to Improving Maternal Mental Health
For mothers, increased duration of leave was associated with reduced risk of depressive symptoms, less psychological distress, and lower use of mental health services.
New Research at the Center for Women’s Mental Health: The MGH Postpartum Psychosis Project
Although the last decade has brought increased awareness of and interest in postpartum mood and anxiety disorders, our understanding of the etiology of this most severe form of postpartum mental illness remains elusive.
National Eating Disorder Awareness Week: Focus on Pregnant and Postpartum Women
Eating disorders are common among women during the childbearing years; however, information on eating disorders in pregnant and postpartum women is relatively sparse.
Canadian Task Force recommendation on screening for postpartum depression misses the mark
Dr. Lee S. Cohen, Director of the Ammon-Pinizzotto Center for Women's Mental Health at Massachusetts General Hospital, recently shared his insights on the new recommendation by the Canadian Task Force on Preventative Health Care which advises against systematic questionnaires for PPD screening with Ob.Gyn News on January 20, 2023.
Emergency Resources for Individuals with Perinatal Mental Health Issues
This very helpful list from Wendy Davis, PhD, Executive Director of Postpartum Support International, describes what the various emergency services can provide.
Zuranolone: Novel, Rapid-Acting Antidepressant Awaits FDA Approval
A New Drug Application for zuranolone awaits FDA approval for the treatment of major depressive disorder (MDD) and postpartum depression (PPD).
Essential Reads: Peer Support Interventions for Perinatal Depression
Peer support interventions can reduce the incidence of postpartum depression and the severity of depressive symptoms.